Screening Study for Participants With Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE1
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of INCB123667 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
- Status
- RECRUITING
- Phase
- PHASE4
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE2
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of TAK-103 in Adult With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
- Status
- SUSPENDED
- Phase
- PHASE1
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A